Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,264 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Recommendations for defining preventable HIV-related mortality for public health monitoring in the era of Getting to Zero: an expert consensus.
Croxford SE, Martin V, Lucas SB, Miller RF, Post FA, Anderson J, Apea VJ, Asboe D, Brough G, Chadwick DR, Collins S, Corkin H, Dean G, Delpech VC, Gogia M, Gold D, Kafkalias A, Korkodilos M, Kowalska JD, Lindo J, Lundgren JD, Lynch L, Martinez E, McDougall N, North S, Rockstroh JK, Sabin C, Vidal-Read M, Waters LJ, Sullivan AK. Croxford SE, et al. Among authors: collins s. Lancet HIV. 2023 Mar;10(3):e195-e201. doi: 10.1016/S2352-3018(22)00363-0. Epub 2023 Jan 4. Lancet HIV. 2023. PMID: 36610439 Review.
Frequency and patterns of protease gene resistance mutations in HIV-infected patients treated with lopinavir/ritonavir as their first protease inhibitor.
Barber TJ, Harrison L, Asboe D, Williams I, Kirk S, Gilson R, Bansi L, Pillay D, Dunn D; UK HIV Drug Resistance Database and UK Collaborative HIV Cohort (UK CHIC) Study Steering Committees. Barber TJ, et al. J Antimicrob Chemother. 2012 Apr;67(4):995-1000. doi: 10.1093/jac/dkr569. Epub 2012 Jan 17. J Antimicrob Chemother. 2012. PMID: 22258921
Low frequency of genotypic resistance in HIV-1-infected patients failing an atazanavir-containing regimen: a clinical cohort study.
Dolling DI, Dunn DT, Sutherland KA, Pillay D, Mbisa JL, Parry CM, Post FA, Sabin CA, Cane PA; UK HIV Drug Resistance Database (UKHDRD); UK Collaborative HIV Cohort Study (UK CHIC). Dolling DI, et al. J Antimicrob Chemother. 2013 Oct;68(10):2339-43. doi: 10.1093/jac/dkt199. Epub 2013 May 27. J Antimicrob Chemother. 2013. PMID: 23711895 Free PMC article.
No Evidence That HIV-1 Subtype C Infection Compromises the Efficacy of Tenofovir-Containing Regimens: Cohort Study in the United Kingdom.
White E, Smit E, Churchill D, Collins S, Booth C, Tostevin A, Sabin C, Pillay D, Dunn DT; UK HIV Drug Resistance Database and UK Collaborative HIV Cohort Study. White E, et al. Among authors: collins s. J Infect Dis. 2016 Nov 1;214(9):1302-1308. doi: 10.1093/infdis/jiw213. Epub 2016 May 24. J Infect Dis. 2016. PMID: 27732929 Free PMC article.
Time trends in drug resistant HIV-1 infections in the United Kingdom up to 2009: multicentre observational study.
UK Collaborative Group on HIV Drug Resistance; Dolling D, Sabin C, Delpech V, Smit E, Pozniak A, Asboe D, Brown AL, Churchill D, Williams I, Geretti AM, Phillips A, Mackie N, Murphy G, Castro H, Pillay D, Cane P, Dunn D, Dolling D. UK Collaborative Group on HIV Drug Resistance, et al. BMJ. 2012 Aug 21;345:e5253. doi: 10.1136/bmj.e5253. BMJ. 2012. PMID: 22915687 Free PMC article.
Persistence of HIV-1 transmitted drug resistance mutations.
Castro H, Pillay D, Cane P, Asboe D, Cambiano V, Phillips A, Dunn DT; UK Collaborative Group on HIV Drug Resistance. Castro H, et al. J Infect Dis. 2013 Nov 1;208(9):1459-63. doi: 10.1093/infdis/jit345. Epub 2013 Jul 31. J Infect Dis. 2013. PMID: 23904291 Free PMC article.
4,264 results